Abstract
Mycobacterium tuberculosis, the causative agent of tuberculosis, has a lipid-rich cell wall that serves as an effective barrier against drugs and toxic host cell products, which may contribute to the organism’s persistence in a host. M. tuberculosis contains four homologous operons called nice (mce1–4) that encode putative ABC transporters involved in lipid importation across the cell wall. Here, we analyzed the lipid composition of M. tuberculosis disrupted in the mce2 operon. High resolution mass spectrometric and thin layer chromatographic analyses of the mutant’s cell wall lipid extracts showed accumulation of SL-1 and SL1278 molecules. Radiographic quantitative analysis and densitometry revealed 2.9, 3.9 and 9.8-fold greater amount of [35S] SL-1 in the mce2 operon mutant compared to the wild type M. tuberculosis during the early/mid logarithmic, late logarithmic and stationary phase of growth in liquid broth, respectively. The amount of [35S] SL1278 in the mutant also increased progressively over the same growth phases. The expression of the mce2 operon genes in the wild type strain progressively increased from the logarithmic to the stationary phase of bacterial growth in vitro, which inversely correlated with the proportion of radiolabel incorporation into SL-1 and SL1278 at these phases. Since the mce2 operon is regulated in wild type M. tuberculosis, its cell wall may undergo changes in SL-1 and SL1278 contents during a natural course of infection and this may serve as an important adaptive strategy for M. tuberculosis to maintain persistence in a host.
Similar content being viewed by others
References
Belanger, A.E. and J.M. Inamine. 2000. Genetics of Cell Wall Biosynthesis, pp. 191–202. In G.F. Hartfull and W.R.J. Jacobs (eds.), Molecular Genetics of Mycobacteria. American Society of Microbiology, Washington, DC, USA.
Besra, G.S. and P.J. Brennan. 1997. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan. Biochem. Soc. Trans. 25, 845–850.
Brennan, P.J. and P. Draper. 1994. Ultrastructure of Mycobacterium tuberculosis, pp. 271–306. In B.R. Bloom (ed.), Tuberculosis: Pathogenesis, Protection and Control. ASM Press, Washington, DC, USA.
Casali, N. and L.W. Riley. 2007. A phylogenomic analysis of the Actinomycetales mce operons. BMC Genomics 8, 60.
Converse, S.E., J.D. Mougous, M.D. Leavell, J.A. Leary, C.R. Bertozzi, and J.S. Cox. 2003. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. USA 100, 6121–6126.
Daffe, M. and P. Draper. 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39, 131–203.
Dassa, E. and P. Bouige. 2001. The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Res. Microbiol. 152, 211–229.
Dobson, G., D.E. Minnikin, S.M. Minnikin, J.H. Parlett, M. Goodfellow, M. Ridell, and M. Magnusson. 1985. Systematic analysis of complex mycobacterial lipids, pp. 237–265. In M. Goodfellow and D.E. Minnikin (eds.), Chemical Methods in Bacterial Systematics. Academic Press, London, UK.
Dunphy, K.Y., R.H. Senaratne, M. Masuzawa, L.V. Kendall, and L.W. Riley. 2010. Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5. J. Infect. Dis. 201, 1232–1239.
Fratti, R.A., J. Chua, I. Vergne, and V. Deretic. 2003. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA 100, 5437–5442.
Gangadharam, P.R., M.L. Cohn, and G. Middlebrook. 1963. Infectivity, pathogenicity and sulpholipid fraction of some Indian and British strains of tubercle Bacilli. Tubercle 44, 452–455.
Geisel, R.E., K. Sakamoto, D.G. Russell, and E.R. Rhoades. 2005. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J. Immunol. 174, 5007–5015.
Houben, E.N., L. Nguyen, and J. Pieters. 2006. Interaction of pathogenic mycobacteria with the host immune system. Curr. Opin. Microbiol. 9, 76–85.
Kumar, P., M.W. Schelle, M. Jain, F.L. Lin, C.J. Petzold, M.D. Leavell, J.A. Leary, J.S. Cox, and C.R. Bertozzi. 2007. PapA1 and PapA2 are acyltransferases essential for the biosynthesis of the Mycobacterium tuberculosis virulence factor sulfolipid-1. Proc. Natl. Acad. Sci. USA 104, 11221–11226.
Lin, H.H., D.E. Faunce, M. Stacey, A. Terajewicz, T. Nakamura, J. Zhang-Hoover, M. Kerley, M.L. Mucenski, S. Gordon, and J. Stein-Streilein. 2005. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J. Exp. Med. 201, 1615–1625.
Livak, K.J. and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402–408.
Marjanovic, O., T. Miyata, A. Goodridge, L.V. Kendall, and L.W. Riley. 2010. Mce2 operon mutant strain of Mycobacterium tuberculosis is attenuated in C57BL/6 mice. Tuberculosis 90, 50–56.
Marshall, A.G., C.L. Hendrickson, and G.S. Jackson. 1998. Mass spectrom. Review 17, 1–35.
Middlebrook, G., C.M. Coleman, and W.B. Schaefer. 1959. Sulfolipid from virulent tubercle Bacilli. Proc. Natl. Acad. Sci. USA 45, 1801–1804.
Minnikin, D.E. 1982. Lipids: complex lipids, their chemistry, biosynthesis and roles, pp. 95–184. In C. Ratledge and J. Stanford(eds.), The Biology of Mycobacteria. Academic Press, Ltd., London, UK.
Okamoto, Y., Y. Fujita, T. Naka, M. Hirai, I. Tomiyasu, and I. Yano. 2006. Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-alpha release. Microb. Pathog. 40, 245–253.
Pandey, A.K. and C.M. Sassetti. 2008. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. USA 105, 4376–4380.
Parish, T. and N.G. Stoker. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146, 1969–1975.
Rao, V., N. Fujiwara, S.A. Porcelli, and M.S. Glickman. 2005. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 201, 535–543.
Reed, M.B., P. Domenech, C. Manca, H. Su, A.K. Barczak, B.N. Kreiswirth, G. Kaplan, and C.E. Barry, 3rd. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84–87.
Rousseau, C., O.C. Turner, E. Rush, Y. Bordat, T.D. Sirakova, P.E. Kolattukudy, S. Ritter, I.M. Orme, B. Gicquel, and M. Jackson. 2003. Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs. Infect. Immun. 71, 4684–4690.
Santangelo Mde, L., F. Blanco, E. Campos, M. Soria, M.V. Bianco, L. Klepp, A. Alito, O. Zabal, A. Cataldi, and F. Bigi. 2009. Mce2R from Mycobacterium tuberculosis represses the expression of the mce2 operon. Tuberculosis 89, 22–28.
Senaratne, R.H., B. Sidders, P. Sequeira, G. Saunders, K. Dunphy, O. Marjanovic, J.R. Reader, and et al. 2008. Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice. J. Med. Microbiol. 57, 164–170.
Shimono, N., L. Morici, N. Casali, S. Cantrell, B. Sidders, S. Ehrt, and L.W. Riley. 2003. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc. Natl. Acad. Sci. USA 100, 15918–15923.
Stacey, M., G.W. Chang, J.Q. Davies, M.J. Kwakkenbos, R.D. Sanderson, J. Hamann, S. Gordon, and H.H. Lin. 2003. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 102, 2916–2924.
Vergne, I., J. Chua, S.B. Singh, and V. Deretic. 2004. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell. Dev. Biol. 20, 367–394.
Zhang, L., D. English, and B.R. Andersen. 1991. Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid-1. J. Immunol. 146, 2730–2736.
Zhang, L., J.C. Gay, D. English, and B.R. Andersen. 1994. Neutrophil priming mechanisms of sulfolipid-I and N-formyl-methionyl-leucyl-phenylalanine. J. Biomed. Sci. 1, 253–262.
Zhang, L., M.B. Goren, T.J. Holzer, and B.R. Andersen. 1988. Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect. Immun. 56, 2876–2883.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplemental material for this article may be found at http://www.springer.com/content/120956
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Marjanovic, O., Iavarone, A.T. & Riley, L.W. Sulfolipid accumulation in Mycobacterium tuberculosis disrupted in the mce2 operon. J Microbiol. 49, 441–447 (2011). https://doi.org/10.1007/s12275-011-0435-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-011-0435-4